ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
Connor, Clark & Lunn Investment Management Ltd. 182,235$6,496,6780.03%
Jump Financial, LLC 23,436$835,4930.03%
BOOTHBAY FUND MANAGEMENT, LLC 37,591$1,340,1190.03%
Trexquant Investment LP 29,548$1,053,3860.03%
E Fund Management Co., Ltd. 9,404$3350.02%
Assenagon Asset Management S.A. 210,921$7,519,3340.02%
Engineers Gate Manager LP 17,556$625,8710.02%
ALLIANCEBERNSTEIN L.P. 1,532,505$54,633,8030.02%
DEUTSCHE BANK AG\ 947,732$33,786,6460.02%
TWO SIGMA ADVISERS, LP 229,500$8,181,6750.02%
Walleye Capital LLC 230,005$8,199,6780.02%
Covestor Ltd 748$270.02%
China Universal Asset Management Co., Ltd. 1,831$650.02%
Aquatic Capital Management LLC 12,800$4560.02%
GREAT LAKES ADVISORS, LLC 55,447$1,976,6860.02%
Mirae Asset Global Investments Co., Ltd. 210,968$7,521,0090.02%
PRICE T ROWE ASSOCIATES INC /MD/ 3,160,160$112,6610.02%
Russell Investments Group, Ltd. 183,887$6,555,5700.01%
Candriam S.C.A. 49,480$1,763,9620.01%
Caption Management, LLC 22,500$802,1250.01%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q3 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.